These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 22920235
1. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study. Tam LS, Shang Q, Li EK, Wong S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM. Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235 [Abstract] [Full Text] [Related]
6. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension. Dimitriadis K, Tsioufis C, Kasiakogias A, Miliou A, Poulakis M, Kintis K, Bafakis I, Benardis E, Tousoulis D, Stefanadis C. Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601 [Abstract] [Full Text] [Related]
8. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH. Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738 [Abstract] [Full Text] [Related]
10. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study. Guin A, Chatterjee Adhikari M, Chakraborty S, Sinhamahapatra P, Ghosh A. Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602 [Abstract] [Full Text] [Related]
12. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities. Arida A, Protogerou AD, Konstantonis G, Fragiadaki K, Kitas GD, Sfikakis PP. Rheumatology (Oxford); 2017 Jun 01; 56(6):934-939. PubMed ID: 28160488 [Abstract] [Full Text] [Related]
15. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB. Circulation; 2006 Sep 12; 114(11):1185-92. PubMed ID: 16952987 [Abstract] [Full Text] [Related]
16. Effect of Treat-to-target Strategies Aiming at Remission of Arterial Stiffness in Early Rheumatoid Arthritis: A Randomized Controlled Study. Tam LH, Shang Q, Li EK, Wong PC, Kwok KY, Kun EW, Yim IC, Lee VK, Yip RM, Pang SH, Lao VW, Mak QW, Cheng IT, Lau XS, Li TK, Zhu TY, Lee AP, Tam LS. J Rheumatol; 2018 Aug 12; 45(9):1229-1239. PubMed ID: 29764965 [Abstract] [Full Text] [Related]
17. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Wong M, Oakley SP, Young L, Jiang BY, Wierzbicki A, Panayi G, Chowienczyk P, Kirkham B. Ann Rheum Dis; 2009 Aug 12; 68(8):1277-84. PubMed ID: 18930987 [Abstract] [Full Text] [Related]
18. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Pullerits R, d'Elia HF, Tarkowski A, Carlsten H. Rheumatology (Oxford); 2009 Jul 12; 48(7):785-90. PubMed ID: 19416946 [Abstract] [Full Text] [Related]